MISSION Therapeutics

About:

MISSION Therapeutics develops therapies that enhance the removal of dysfunctional mitochondria to combat serious diseases.

Website: http://www.missiontherapeutics.com

Twitter/X: MISSIONTherapeu

Top Investors: Innovate UK, IP Group, SR One, Sofinnova Partners, Michael J. Fox Foundation

Description:

MISSION Therapeutics is a biotechnology company specializing in developing drugs that target the cellular process of deubiquitylation for the treatment of cancer and other diseases. Their focus is on developing small molecule drugs that selectively inhibit specific deubiquitylating enzymes (DUBs), which play crucial roles in regulating protein degradation and cellular processes. These drugs aim to intervene in disease mechanisms where DUB dysregulation is implicated, offering potential therapeutic benefits.